GlassScriptPhysician profile
Pratik Vaidya
NPI 1568016913
$2,745.31
in general payments reported to CMS, 2019-2025
16 companies · $736 in 2025
The $736 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.87 · 2022: $997 · 2023: $613 · 2024: $348 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,696.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,380.36 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $540.70 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Idorsia Pharmaceuticals US INC | $157.77 | 2022-2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $125.30 | 2025 | Breztri |
| Axsome Therapeutics, INC. | $110.00 | 2025 | Auvelity |
| Daiichi Sankyo INC. | $78.84 | 2024 | Injectafer |
| Abbvie INC. | $73.40 | 2023-2025 | |
| Corcept Therapeutics | $62.70 | 2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $42.39 | 2022-2023 | Trintellix |
| Insulet Corporation | $39.78 | 2024 | Omnipod |
| Exact Sciences Corporation | $30.04 | 2025 | The Cologuard Plus Collection Kit |
| Tolmar, INC. | $27.69 | 2024-2025 | Jatenzo |
| Xeris Pharmaceuticals, INC. | $23.50 | 2024 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $20.31 | 2023 | Verquvo, Belsomra |
| Eisai INC. | $16.30 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $16.23 | 2023 | Edarbyclor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pratik Vaidya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.